Pharmacological knowledge and sustainable anthelmintic therapy in ruminants

Veterinary Parasitology

Volumn 204, Issue 1-2, 2014, Pages 18-33

  Lanusse, Carlos ^a   Alvarez, Luis ^a   Lifschitz, Adrian ^a  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Anthelmintic therapy; Drug resistance; Pharmacological knowledge; Ruminants

Indexed keywords

ABAMECTIN; ALBENDAZOLE; ANTHELMINTIC AGENT; DERQUANTEL; IVERMECTIN; LEVAMISOLE; MACROLIDE; MONEPANTEL; MULTIDRUG RESISTANCE PROTEIN; TRICLABENDAZOLE;

ANTIBIOTIC RESISTANCE; AREA UNDER THE CURVE; ARTICLE; BOVIDS; COMBINATION CHEMOTHERAPY; DRUG ABSORPTION; DRUG ANTAGONISM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG EXCRETION; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENTIATION; DRUG SAFETY; DRUG TRANSPORT; DRUG USE; HELMINTHIASIS; MULTIDRUG RESISTANCE; NEMATODIASIS; NONHUMAN; PARASITE CONTROL; PHARMACOLOGY;

ANIMALIA; VERMES;

ANTHELMINTIC THERAPY; DRUG RESISTANCE; PHARMACOLOGICAL KNOWLEDGE; RUMINANTS;

ANIMALS; ANTHELMINTICS; COMMUNICABLE DISEASE CONTROL; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; HELMINTHIASIS, ANIMAL; PHARMACOLOGICAL PHENOMENA; RUMINANTS;

EID: 84904384566     PISSN: 03044017     EISSN: 18732550     Source Type: Journal    
DOI: 10.1016/j.vetpar.2013.11.003     Document Type: Article

References (104)

1. Alka Gopal R.M., Sandhu K.S., Sidhu P.K. Efficacy of abamectin against ivermectin-resistant strain of Trichostrongylus colubriformis in sheep. Vet. Parasitol. 2004, 121:277-283.
2. Allen J.D., Schinkel A.H. Multidrug resistance and pharmacological protection mediated by the breast cancer resistance protein (BCRP/ABCG2). Mol. Cancer Ther. 2002, 1:427-434.
3. Alvarez L., Sánchez S., Lanusse C. In vivo and ex vivo uptake of albendazole and its sulphoxide metabolite by cestode parasites: relationship with their kinetics behaviour in sheep. J. Vet. Pharmacol. Ther. 1999, 22:77-86.
4. Alvarez L., Imperiale F., Sánchez S., Murno G., Lanusse C. Uptake of albendazole and albendazole sulphoxide by Haemonchus contortus and Fasciola hepatica in sheep. Vet. Parasitol. 2000, 94:75-89.
5. Alvarez L.I., Mottier M.L., Lanusse C.E. Drug transfer into target helminth parasites. Trends Parasitol. 2007, 23:97-104.
6. Alvarez L., Lifschitz A., Entrocasso C., Manazza J., Mottier L., Borda B., Virkel G., Lanusse C. Evaluation of the interaction between ivermectin and albendazole following their combined use in lambs. J. Vet. Pharmacol. Ther. 2008, 31:230-239.
7. Alvarez L., Entrocasso C., Lifschitz A., Manazza J., Ceballos L., Borda B., Lanusse C. Albendazole failure to control resistant nematodes in lambs: lack of effect of fasting-induced improvement on drug absorption. J. Parasitol. 2010, 96:1204-1210.
8. Alvarez L., Suarez G., Ceballos L., Moreno L., Lanusse C. Differential exposure of Haemonchus contortus to albendazole according to the site of worm location in the abomasum of infected sheep. Proceedings of 23rd International Conference of the World Association for the Advancement of Veterinary Parasitology 2011, 128. (abstract only).
9. Alvarez L., Suarez G., Ceballos L., Moreno L., Lanusse C. Dose-dependent systemic exposure of albendazole metabolites in lambs. J. Vet. Pharmacol. Ther. 2012, 35:365-372.
10. Alvarez L., Domingue G., Moreno L., Ceballos L., Bistoletti M., Donadeu M., Lanusse C. Testing high oxfendazole doses to treat cysticercosis in pigs: a safety assessment. Proceedings of 12th International Congress of the European Association for Veterinary Pharmacology and Toxicology 2012, 201-202. (abstract only).
11. Alvinerie M., Dupuy J., Eeckhoutte C., Sutra J.F. Enhanced absorption of pour-on ivermectin formulation in rats by co-administration of the multidrug-resistant-reversing agent verapamil. Parasitol. Res. 1999, 85:920-922.
12. Alvinerie M., Dupuy J., Kiki-Mvouaka S., Sutra J., Lespine A. Ketoconazole increases the plasma levels of ivermectin in sheep. Vet. Parasitol. 2008, 157:117-122.
13. Anderson N., Martin P.J., Jarrett R.G. Mixtures of anthelmintics: a strategy against resistance. Aust. Vet. J. 1988, 65:62-64.
14. Anderson N., Martin P.J., Jarret R.G. The efficacy of mixtures of albendazole sulphoxide and levamisole against sheep nematodes resistant to benzimidazole and levamisole. Aust. Vet. J. 1991, 68:127-132.
15. Anderson N., Martin P.J., Jarret R.G. Field evaluation of a mixture of albendazole sulphoxide and levamisole against Ostertagia and Trichostrongylus spp. in sheep. Aust. Vet. J. 1991, 68:133-136.
16. Ardelli B.F., Prichard R.K. Inhibition of P-glycoprotein enhances sensitivity of Caenorhabditis elegans to ivermectin. Vet. Parasitol. 2013, 191:264-275.
17. Awadzi K., Edwards G., Opoku N., Ardrey A., Favager S., Addy E., Attah S., Yamuah L., Quartey B. The safety, tolerability and pharmacokinetics of levamisole alone, levamisole plus ivermectin, and levamisole plus albendazole, and their efficacy against Onchocerca volvulus. Ann. Trop. Med. Parasitol. 2004, 98:595-614.
18. Ballent M., Lifschitz A., Virkel G., Sallovitz J., Lanusse C. Modulation of the P-glycoprotein-mediated intestinal secretion of ivermectin: in vitro and in vivo assessments. Drug Metab. Dispos. 2006, 34:457-463.
19. Ballent M., Lifschitz A., Virkel G., Sallovitz J., Lanusse C. Involvement of P-glycoprotein on ivermectin kinetic behaviour in sheep: itraconazole-mediated changes on gastrointestinal disposition. J. Vet. Pharmacol. Ther. 2007, 30:242-248.
20. Ballent M., Lifschitz A., Virkel G., Maté L., Lanusse C. Pretreatment with the inducers rifampicin and phenobarbital alters ivermectin gastrointestinal disposition. J. Vet. Pharmacol. Ther. 2010, 33:252-259.
21. Ballent M., Lifschitz A., Virkel G., Sallovitz J., Maté L., Lanusse C. In vivo and ex vivo assessment of the interaction between ivermectin and danofloxacin in sheep. Vet. J. 2012, 192:422-427.
22. Ballent M., Wilkens M.R., Maté L., Muscher A.S., Virkel G., Sallovitz J., Schröder B., Lanusse C., Lifschitz A. P-glycoprotein in sheep liver and small intestine: gene expression and transport efflux activity. J. Vet. Pharmacol. Ther. 2013, (in press). 10.1111/jvp.12040.
23. Barrère V., Alvarez L., Suarez G., Ceballos L., Moreno L., Lanusse C., Prichard R. Relationship between increased albendazole systemic exposure and changes in single nucleotide polymorphisms on the beta-tubulin isotype 1 encoding gene in Haemonchus contortus. Vet. Parasitol. 2012, 186:344-349.
24. Bartley D.J., McAllister H., Bartley Y., Dupuy J., Ménez C., Alvinerie M., Jackson F., Lespine A. P-glycoprotein interfering agents potentiate ivermectin susceptibility in ivermectin sensitive and resistant isolates of Teladorsagia circumcincta and Haemonchus contortus. Parasitology 2009, 136:1081-1088.
25. Bartley D.J., Morrison A.A., Dupuy J., Bartley Y., Sutra J.F., Menez C., Alvinerie M., Jackson F., Devin L., Lespine A. Influence of Pluronic 85 and ketoconazole on disposition and efficacy of ivermectin in sheep infected with a multiple resistant Haemonchus contortus isolate. Vet. Parasitol. 2012, 187:464-472.
26. Bartram D.J., Leathwick D.M., Taylor M.A., Geurden T., Maeder S.J. The role of combination anthelmintic formulations in the sustainable control of sheep nematodes. Vet. Parasitol. 2012, 186:151-158.
27. Bennet E., Behm C., Bryant C., Chevis R. Synergistic action of mebendazole and levamisole in the treatment of a benzimidazole-resistant Haemonchus contortus in sheep. Vet. Parasitol. 1980, 7:207-214.
28. Blackhall W.J., Pouliot J.F., Prichard R.K., Beech R.N. Haemonchus contortus: selection at a glutamate-gated chloride channel gene in ivermectin- and moxidectin-selected strains. Exp. Parasitol. 1998, 90:42-48.
29. Bogan J., McKellar Q. The pharmacodynamics of ivermectin in sheep and cattle. J. Vet. Pharmacol. Ther. 1988, 11:260-268.
30. Borgsteede F. The efficacy and persistent anthelmintic effect of ivermectin in sheep. Vet. Parasitol. 1993, 50:117-124.
31. Boulin T., Fauvin A., Charvet C., Cortet J., Cabaret J., Bessereau J.L., Neveu C. Functional reconstitution of Haemonchus contortus acetylcholine receptors in Xenopus Oocytes provides mechanistic insights into levamisole resistance. Br. J. Pharmacol. 2011, 164:1421-1432.
32. Bourgeois B. Methods for assessing pharmacodynamic interactions. Antiepileptic Drugs Combination Therapy and Interactions 2005, 193-207. Cambridge University Press, Cambridge, UK. E. Majkowski, B. Bourgeois, P. Patsalos, R. Mattson (Eds.).
33. Ceballos L., Moreno L., Alvarez L., Shaw L., Fairweather I., Lanusse C. Unchanged triclabendazole kinetics after co-administration with ivermectin and methimazole: failure of its therapeutic activity against triclabendazole-resistant liver flukes. BMC Vet. Res. 2010, 6:8.
34. Cromie L., Ferry M., Couper A., Fields C., Taylor S.M. Pharmacokinetics of a novel closantel/ivermectin injection in cattle. J. Vet. Pharmacol. Ther. 2006, 29:205-211.
35. Demeler J., Van Zeveren A.M., Kleinschmidt N., Vercruysse J., Höglund J., Koopmann R., Cabaret J., Claerebout E., Areskog M., von Samson-Himmelstjerna G. Monitoring the efficacy of ivermectin and albendazole against gastro intestinal nematodes of cattle in Northern Europe. Vet. Parasitol. 2009, 160:109-115.
36. Demeler J., Krücken J., Algusbi S., Ramünke S., De Graef J., Kerboeuf D., Geldhof P., Pomroy W.E., von Samson-Himmelstjerna G. Potential contribution of P-glycoproteins to macrocyclic lactone resistance in the cattle parasitic nematode Cooperia oncophora. Mol. Biochem. Parasitol. 2013, 188:10-19.
37. Didier A., Loor F. The abamectin derivative ivermectin is a potent P-glycoprotein inhibitor. Anticancer Drugs 1996, 7:745-751.
38. Dobson R.J., Besier R.B., Barnes E.H., Love S.C.J., Vizard A., Bell K., Le Jambre L.F. Principles of use of macrocyclic lactones to minimise selection for resistance. Aust. Vet. J. 2001, 79:756-761.
39. Dupuy J., Larrieu G., Sutra J.F., Lespine A., Alvinerie M. Enhancement of moxidectin bioavailability in lamb by a natural flavonoid: quercetin. Vet. Parasitol. 2003, 112:337-347.
40. Dupuy J., Alvinerie M., Ménez C., Lespine A. Interaction of anthelmintic drugs with P-glycoprotein in recombinant LLC-PK1-mdr1a cells. Chem. Biol. Interact. 2010, 186:280-286.
41. El-Abdellati A., Charlier J., Geldhof P., Levecke B., Demeler J., von Samson-Himmelstjerna G., Claerebout E., Vercruysse J. The use of a simplified faecal egg count reduction test for assessing anthelmintic efficacy on Belgian and German cattle farms. Vet. Parasitol. 2010, 169:352-357.
42. El-Banna H., Goudah A., El-Zorba H., Abd-El-Rahman S. Comparative pharmacokinetics of ivermectin alone and a novel formulation of ivermectin and rafoxanide in calves and sheep. Parasitol. Res. 2008, 102:1337-1342.
43. Entrocasso C., Alvarez L., Manazza J., Lifschitz A., Borda B., Virkel G., Mottier L., Lanusse C. Clinical efficacy assessment of the albendazole-ivermectin combination in lambs parasitized with resistant nematodes. Vet. Parasitol. 2008, 155:249-256.
44. FDA/CVM Guidance document #35 of 1996, and released in November, 2006 2006, http://www.fda.gov/downloads/AnimalVeterinary/GuidanceComplianceEnforcement/GuidanceforIndustry/UCM052363.pdf.
45. Fetsch P.A., Abati A., Litman T., Morisaki K., Honjo Y., Mittal K., Bates S.E. Localization of the ABCG2 mitoxantrone resistance-associated protein in normal tissues. Cancer Lett. 2006, 235:84-92.
46. Geary T.G., Sangster N.C., Thompson D.P. Frontiers in anthelmintic pharmacology. Vet. Parasitol. 1999, 84:275-295.
47. Geary T.G., Hosking B.C., Skuce P.J., von Samson-Himmelstjerna G., Maeder S., Holdsworth P., Pomroy W., Vercruysse J. World Association for the Advancement of Veterinary Parasitology (W.A.A.V.P.) Guideline. Anthelmintic combination products targeting nematode infections of ruminants and horses. Vet. Parasitol. 2012, 190:306-316.
48. Gibaldi M., Perrier D. Pharmacokinetics 1982, 494. Marcel Dekker, NewYork.
49. Gopal R.M., West D.M., Pomroy W.E. The difference in efficacy of ivermectin oral, moxidectin oral and moxidectin injectable formulations against an ivermectin-resistant strain of Trichostrongylus colubriformis in sheep. N. Z. Vet. J. 2001, 49:133-137.
50. Griffin J., Fletcher N., Clemence R., Blanchflower S., Brayden D.J. Selamectin is a potent substrate and inhibitor of human and canine P-glycoprotein. J. Vet. Pharmacol. Ther. 2005, 28:257-265.
51. Kaminsky R., Ducray P., Jung M., Clover R., Rufener L., Bouvier J., Weber S.S., Wenger A., Wieland-Berghausen S., Goebel T., Gauvry N., Pautrat F., Skripsky T., Froelich O., Komoin-Oka C., Westlund B., Sluder A., Mäser P. A new class of anthelmintics effective against drug-resistant nematodes. Nature 2008, 452:176-180.
52. Kaminsky R., Bapst B., Stein P., Strehlau G., Allan B., Hosking B., Rolfe P., Sager H. Differences in efficacy of monepantel, derquantel and abamectin against multi-resistant nematodes of sheep. Parasitol. Res. 2011, 109:19-23.
53. Kaplan R.M. Drug resistance in nematodes of veterinary importance: a status report. Trends Parasitol. 2004, 20:477-481.
54. Karadzovska D., Seewald W., Browning A., Smal M., Bouvier J., Giraudel J. Pharmacokinetics of monepantel and its sulfone metabolite, monepantel sulfone, after intravenous and oral administration in sheep. J. Vet. Pharmacol. Ther. 2009, 32:359-367.
55. Kerboeuf D., Guegnard F., Le Vern Y. Analysis and partial reversal of multidrug resistance to anthelmintics due to P-glycoprotein in Haemonchus contortus eggs using Lens culinaris lectin. Parasitol. Res. 2002, 88:816-821.
56. Kwa M.S.G., Veenstra J.G., Van Dijk M., Roos M.H. β-tubulin genes from the parasitic nematode Haemonchus contortus modulate drug resistance in Caenorhabditis elegans. J. Mol. Biol. 1995, 246:500-510.
57. Lanusse C. Comparative pharmacokinetics of anthelmintic drugs in ruminants. Updated integration of available knowledge. J. Vet. Pharmacol. Ther. 2003, 26:42-47.
58. Leathwick D.M., Miller C.M. Efficacy of oral, injectable and pour-on formulations of moxidectin against gastrointestinal nematodes in cattle in New Zealand. Vet. Parasitol. 2013, 191:293-300.
59. Lespine A., Alvinerie M., Sutra J.F., Pors I., Chartier C. Influence of the route of administration on efficacy and tissue distribution of ivermectin in goat. Vet. Parasitol. 2005, 128:251-260.
60. Lespine A., Martin S., Dupuy J., Roulet A., Pineau T., Orlowski S., Alvinerie M. Interaction of macrocyclic lactones with P-glycoprotein: structure-affinity relationship. Eur. J. Pharmacol. Sci. 2007, 30:84-94.
61. Lespine A., Alvinerie M., Vercruysse J., Prichard R.K., Geldhof P. ABC transporter modulation: a strategy to enhance the activity of macrocyclic lactone anthelmintics. Trends Parasitol. 2008, 24:293-298.
62. Lespine A., Ménez C., Bourguinat C., Prichard R.K. P-glycoproteins and other multidrug resistance transporters in the pharmacology of anthelmintics: Prospects for reversing transport-dependent anthelmintic resistance. Int. J. Parasitol. Drugs Drug Resist. 2012, 2:58-75.
63. Lifschitz A., Virkel G., Sallovitz J., Imperiale F., Pis A., Lanusse C. Loperamide-induced enhancement of moxidectin availability in cattle. J. Vet. Pharmacol. Ther. 2002, 25:111-120.
64. Lifschitz A., Virkel G., Ballent M., Sallovitz J., Lanusse C. Combined use of ivermectin and triclabendazole in sheep: in vitro and in vivo characterisation of their pharmacological interaction. Vet. J. 2009, 182:261-268.
65. Lifschitz A., Suarez V.H., Sallovitz J., Cristel S.L., Imperiale F., Ahoussou S., Schiavi C., Lanusse C. Cattle nematodes resistant to macrocyclic lactones: comparative effects of P-glycoprotein modulation on the efficacy and disposition kinetics of ivermectin and moxidectin. Exp. Parasitol. 2010, 125:172-178.
66. Lifschitz A., Entrocasso C., Alvarez L., Lloberas M., Ballent M., Manazza G., Virkel G., Borda B., Lanusse C. Interference with P-glycoprotein improves ivermectin activity against adult resistant nematodes in sheep. Vet. Parasitol. 2010, 172:291-298.
67. Lifschitz A., Ballent M., Lanusse C. Macrocyclic lactones and cellular transport-related drug interactions. A perspective from in vitro assays to nematode control in the field. Curr. Pharmacol. Biotechnol. 2012, 13:912-923.
68. Lin J.H. Drug-drug interaction mediated by inhibition and induction of P-glycoprotein. Adv. Drug Deliv. Rev. 2003, 55:53-81.
69. Little P., Hodge A., Maeder S., Wirtherle N., Nicholas D., Cox G., Conder G. Efficacy of a combined oral formulation of derquantel-abamectin against the adult and larval stages of nematodes in sheep, including anthelmintic-resistant strains. Vet. Parasitol. 2011, 181:180-193.
70. Lloberas M., Alvarez L., Entrocasso C., Virkel G., Lanusse C., Lifschitz A. Measurement of ivermectin concentrations in target worms and host gastrointestinal tissues: influence of the route of administration on the activity against resistant Haemonchus contortus in lambs. Exp. Parasitol. 2012, 131:304-309.
71. Lloberas M., Alvarez L., Entrocasso C., Virkel G., Ballent M., Maté L., Lanusse C., Lifschitz A. Comparative tissue pharmacokinetics and efficacy of moxidectin, abamectin and ivermectin in lambs infected with resistant nematodes: Impact of drug treatments on parasite P-glycoprotein expression. Int. J. Parasitol. Drugs Drug Resist. 2013, 3:20-27.
72. Lubega G.W., Prichard R.K. Specific interaction of benzimidazole anthelmintic with tubulin: high affinity binding and benzimidazole resistance in Haemonchus contortus. Mol. Biochem. Parasitol. 1990, 38:221-232.
73. Mehlhorn H., Harder A. Effects of the synergistic action of febantel and pyrantel on the nematode Heterakis spumosa: a light and transmission electron microscopy study. Parasitol. Res. 1997, 83:419-434.
74. Ménez C., Mselli-Lakhal L., Foucaud-Vignault M., Balaguer P., Alvinerie M., Lespine A. Ivermectin induces P-glycoprotein expression and function through mRNA stabilization in murine hepatocyte cell line. Biochem. Pharmacol. 2012, 83:269-278.
75. Merino G., Molina A., García J., Pulido M., Prieto J., Alvarez A. Intestinal elimination of albendazole sulphoxide: pharmacokinetic effects of inhibitors. Int. J. Pharm. 2003, 263:123-132.
76. Merino G., Alvarez A.I., Pulido M.M., Molina A.J., Schinkel A.H., Prieto J.G. Breast cancer resistance protein (BCRP/ABCG2) transports fluoroquinolone antibiotics and affects their oral availability, pharmacokinetics, and milk secretion. Drug Metab. Dispos. 2006, 34:690-695.
77. Miller D.K., Craig T.M. Use of anthelmintic combinations against multiple resistant Haemonchus contortus in Angora goats. Small Rumin. Res. 1996, 19:281-283.
78. Molento M., Lifschitz A., Sallovitz J., Lanusse C., Prichard R.K. Influence of verapamil on the pharmacokinetics of the antiparasitic drugs ivermectin and moxidectin in sheep. Parasitol. Res. 2004, 92:121-127.
79. Mottier L., Alvarez L., Ceballos L., Lanusse C. Drug transport mechanisms in helminth parasites: passive diffusion of benzimidazole anthelmintics. Exp. Parasitol. 2006, 113:49-57.
80. Mottier L., Alvarez L., Fairweather I., Lanusse C. Resistance induced changes in triclabendazole transport in Fasciola hepatica: ivermectin reversal effect. J. Parasitol. 2006, 92:1355-1360.
81. Muenster U., Grieshop B., Ickenroth K., Gnoth M.J. Characterization of substrates and inhibitors for the in vitro assessment of Bcrp mediated drug-drug interactions. Pharm. Res. 2008, 25:2320-2326.
82. Nies A., Spielberg S. Principles of therapeutics. The Pharmacological Basis of Therapeutics 1996, 43-61. McGraw-Hill, New York. J. Hardman, L. Limbird, P. Molinoff, R. Ruddon, A. Goodman Gilman (Eds.).
83. Njue A.I., Prichard R.K. Genetic variability of glutamate-gated chloride channel genes in ivermectin-susceptible and -resistant strains of Cooperia oncophora. Parasitology 2004, 129:741-751.
84. Pérez M., Blazquez A.G., Real R., Mendoza G., Prieto J.G., Merino G., Alvarez A.I. In vitro and in vivo interaction of moxidectin with BCRP/ABCG2. Chem. Biol. Interact. 2009, 180:106-112.
85. Perry B.D., Randolph T.F. Improving the assessment of the economic impact of parasitic diseases and of their control in production animals. Vet. Parasitol. 1999, 84:145-168.
86. Pouliot J.F., L'Heureux F., Liu Z., Prichard R.K., Georges E. Reversal of P-glycoprotein-associated multidrug resistance by ivermectin. Biochem. Pharmacol. 1997, 53:17-25.
87. Pratt W. Drug resistance. Principles of Drug Action. The Basis of Pharmacology 1990, 565-637. Churchill Livingstone, New York, USA. W. Pratt, P. Taylor (Eds.).
88. Prescott J.F. Antimicrobial drug action and interaction: an introduction. Antimicrobial Therapy in Veterinary Medicine 2000, 3-11. Iowa State Press, Iowa. J.F. Prescott, J.D. Baggot, R.D. Walker (Eds.).
89. Prichard R.K., Roulet A. ABC transporters and β-tubulin in macrocyclic lactones resistance: prospects for marker development. Parasitology 2007, 134:1123-1132.
90. Prichard R.K., Menez C., Lespine A. Moxidectin and the avermectins: consanguinity but not identity. Int. J. Parasitol. Drugs Drug Resist. 2012, 2:134-153.
91. Puttachary S., Trailovic S.M., Robertson A.P., Thompson D.P., Woods D.J., Martin R.J. Derquantel and abamectin: effects and interactions on isolated tissues of Ascaris suum. Mol. Biochem. Parasitol. 2013, 188:79-86.
92. Rufener L., Keiser J., Kaminsky R., Maser P., Nilsson D. Phylogenomics of ligand-gated ion channels predicts monepantel effect. PLoS Pathog. 2010, 6(9). 10.1371/journal.ppat.1001091.
93. Ruiz-Lancheros E., Viau C., Walter T.N., Francis A., Geary T.G. Activity of novel nicotinic anthelmintics in cut preparations of Caenorhabditis elegans. Int. J. Parasitol. 2011, 41:455-461.
94. Sallovitz J., Lifschitz A., Imperiale F., Virkel G., Larghi J., Lanusse C. Doramectin concentration profiles in the gastrointestinal tract of topically-treated calves: influence of animal licking restriction. Vet. Parasitol. 2005, 133:61-70.
95. Schinkel A.H. The physiological function of drug-transporting P-glycoproteins. Semin. Cancer Biol. 1997, 8:161-170.
96. Solana H., Rodríguez J., Lanusse C. Comparative metabolism of albendazole and albendazole sulphoxide by different helminth parasites. Parasitol. Res. 2001, 87:275-280.
97. Suarez G., Alvarez L., Castells D., Moreno L., Fagiolino P., Lanusse C. Evaluation of pharmacological interactions after administration of a levamisole, albendazole and ivermectin triple combination in lambs. Vet. Parasitol. 2013, (submitted for publication).
98. Thompson D., Ho N., Sims S., Geary T. Mechanistic approaches to quantitate anthelmintic absorption by gastrointestinal nematodes. Parasitol. Today 1993, 9:31-35.
99. Toutain P.L., Modric S., Bousquet-Mélou A., Sallovitz J.M., Lanusse C. Should licking behavior be considered in the bioavailability evaluation of transdermal products?. J. Vet. Pharmacol. Ther. 2012, 35:39-43.
100. VICH Target Animal Safety for Veterinary Pharmaceuticals Products. GL 43 2008, http://www.vichsec.org/en/guidelines5.htm.
101. Vokřál I., Jirásko R., Stuchlíková L., Bártíková H., Szotáková B., Lamka J., Várady M., Skálová L. Biotransformation of albendazole and activities of selected detoxification enzymes in Haemonchus contortus strains susceptible and resistant to anthelmintics. Vet. Parasitol. 2013, 10.1016/j.vetpar.2013.03.018.
102. Waller P. From discovery to development: current industry perspectives for the development of novel methods of helminth control in livestock. Vet. Parasitol. 2006, 139:1-14.
103. Wolstenholme A., Fairweather I., Prichard R., von Samson-Himmelstjerna G., Sangster V. Drug resistance in veterinary parasites. Trends Parasitol. 2004, 20:469-476.
104. Xu M., Molento M., Blackhall W., Ribeiro P., Beech R., Prichard R.K. Ivermectin resistance in nematodes may be caused by alteration of P-glycoprotein homolog. Mol. Biochem. Parasitol. 1998, 91:327-335.